Related Experiment Videos
Human serum binding capacity and affinity for 25-hydroxyergocalciferol and 25-hydroxycholecalciferol
The Journal of Clinical Endocrinology and Metabolism
|July 1, 1976
Summary
This study investigated 25-hydroxyvitamin D binding in human sera. Maternal and oral contraceptive users showed higher binding capacity, suggesting altered vitamin D metabolism in these groups.
Area of Science:
- Endocrinology
- Biochemistry
- Nutritional Science
Background:
- Vitamin D is crucial for calcium homeostasis and bone health.
- 25-hydroxyvitamin D is the primary circulating metabolite of vitamin D.
- Understanding vitamin D binding in serum is essential for assessing vitamin D status.
Purpose of the Study:
- To characterize the binding capacity and affinity of 25-hydroxyvitamin D in various human serum types.
- To compare vitamin D binding in cord, adult, maternal, and oral contraceptive user sera.
Main Methods:
- In vitro saturation analyses were performed using dextran-coated charcoal to measure binding.
- Radiolabeled 25-hydroxycholecalciferol was used to assess binding affinity and capacity.
- Apparent dissociation constants (Kd) and binding capacities were determined at 0°C.
Main Results:
- 25-hydroxyergocalciferol and 25-hydroxycholecalciferol demonstrated equipotent displacement of 3H 25-hydroxycholecalciferol.
- A low apparent dissociation constant (Kd = 8x10^-10M) was observed for 25-hydroxycholecalciferol serum binding.
- Maternal and oral contraceptive user sera exhibited significantly higher 25-hydroxycholecalciferol binding capacity compared to cord and adult sera.
Conclusions:
- Human serum possesses a high affinity for 25-hydroxyvitamin D.
- Oral contraceptives and pregnancy may alter vitamin D binding protein levels or function.
- Further research is needed to elucidate the clinical implications of altered vitamin D binding in these populations.